(Q35047307)

6 August 2017

title

Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection (English)

1 reference

6 August 2017

Frederick M Hecht

10

0 references

Bruce D. Walker

11

object named as

Bruce D Walker

1 reference

6 August 2017

13

Joseph B Margolick

1 reference

6 August 2017

5

Susan J Little

1 reference

6 August 2017

7

Ann C Collier

1 reference

6 August 2017

6

Jean-Pierre Routy

1 reference

6 August 2017

12

Elizabeth Connick

1 reference

6 August 2017

Linda G Apuzzo

1

1 reference

6 August 2017

Florin Vaida

2

1 reference

6 August 2017

Joel E Gallant

3

1 reference

6 August 2017

Karin B Ernstrom

4

1 reference

6 August 2017

Brian Conway

8

1 reference

6 August 2017

Martin H Markowitz

9

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

Journal of Acquired Immune Deficiency Syndromes

6 August 2017

published in

1 reference

6 August 2017

volume

50

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

267-275

1 reference

High rates of forward transmission events after acute/early HIV-1 infection

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Abacavir hypersensitivity reaction in primary HIV infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Primary HIV-1 infection: to treat or not to treat?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Surveillance for incident HIV infection: new technology and new opportunities

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Detection of acute infections during HIV testing in North Carolina.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Antiretroviral-drug resistance among patients recently infected with HIV.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115738

Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection

25 October 2018

1 reference

12 December 2020

HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients

1 reference

12 December 2020

Development and evaluation of HIV-1 subtype RNA panels for the standardization of HIV-1 NAT assays

1 reference

12 December 2020

The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cells

1 reference

12 December 2020

Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?

1 reference

12 December 2020

Improving HIV Surveillance in Victoria

1 reference

12 December 2020

10.1097/QAI.0B013E3181963AE6

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference